ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.984,32
0,74%
S&P 500
5.970,84
-1,11%
Dow Jones
42.992,21
-0,77%
Euro vs US Dollar
1,04273
-0,01%
Bitcoin
93.515,11
-1,71%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSXV
  6. Tetra Bio Pharma Inc (TBP)

  7. Tetra Bio Pharma Inc (TBP) News

TBP

Tetra Bio Pharma (TBP)

Tetra Bio Pharma Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:TSXV:TBP
DatumZeitQuelleÜberschriftSymbolFirma
17/05/202115h21PR Newswire (Canada)Tetra Bio-Pharma Announces Closing of Bought Deal OfferingTSXV:TBPTetra Bio Pharma Inc
10/05/202123h29PR Newswire (Canada)Tetra Bio-Pharma Announces $10 Million "Bought Deal" Public OfferingTSXV:TBPTetra Bio Pharma Inc
02/03/202115h22PR Newswire (Canada)Tetra Bio-Pharma Announces Closing of Bought Deal OfferingTSXV:TBPTetra Bio Pharma Inc
23/02/202116h42PR Newswire (Canada)Tetra Bio-pharma Inc. Announces Upsizing of Previously Announced OfferingTSXV:TBPTetra Bio Pharma Inc
22/02/202122h47PR Newswire (Canada)Tetra Bio-Pharma Inc. Announces $10 Million Bought Deal Offering of UnitsTSXV:TBPTetra Bio Pharma Inc
03/02/202114h30PR Newswire (Canada)Tetra Bio-Pharma Inc. Announces Closing of Non-Brokered Private PlacementTSXV:TBPTetra Bio Pharma Inc
02/11/202019h51PR Newswire (Canada)Tetra Bio-Pharma Inc. Acquires Common Shares of Mondias Natural Products Inc.TSXV:TBPTetra Bio Pharma Inc
17/08/202014h38PR Newswire (Canada)Tetra Bio-Pharma and Mondias enter into final agreement for the purchase of Lumiera Health Innovation Inc.TSXV:TBPTetra Bio Pharma Inc
30/07/202015h03PR Newswire (Canada)Tetra Bio-Pharma Announces Expected Effective Date of Listing on TSX of its Common Shares and WarrantsTSXV:TBPTetra Bio Pharma Inc
23/07/202016h47PR Newswire (Canada)Tetra and Mondias jointly announce the acquisition of Tetra's subsidiary, Lumiera, by Mondias to create a new growth platformTSXV:TBPTetra Bio Pharma Inc
22/05/202014h49PR Newswire (Canada)Tetra Bio-Pharma Announces Closing of Public OfferingTSXV:TBPTetra Bio Pharma Inc
15/05/202017h09PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - TBPTSXV:TBPTetra Bio Pharma Inc
15/05/202017h07PR Newswire (Canada)IIROC Trading Resumption - TBPTSXV:TBPTetra Bio Pharma Inc
14/05/202021h40PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - TBPTSXV:TBPTetra Bio Pharma Inc
14/05/202021h37PR Newswire (Canada)IIROC Trading Halt - TBPTSXV:TBPTetra Bio Pharma Inc
08/04/202014h00PR Newswire (Canada)Tetra Offers Pro-Bono Regulatory and Quality Assurance Expertise to Companies Developing COVID-19 SolutionsTSXV:TBPTetra Bio Pharma Inc
08/04/202014h00PR Newswire (Canada)Tetra offre de l'expertise réglementaire et en assurance qualité pro-bono à des compagnies qui développent des solutions ...TSXV:TBPTetra Bio Pharma Inc
02/04/202000h12PR Newswire (Canada)Tetra Bio Pharma Announces Filing of Final Base Shelf Prospectus for up to $50 Million of SecuritiesTSXV:TBPTetra Bio Pharma Inc
05/03/202016h30PR Newswire (Canada)Tetra Bio-Pharma Announces Exercise of Over-Allotment Option in Connection with Bought Deal FinancingTSXV:TBPTetra Bio Pharma Inc
20/02/202023h11PR Newswire (Canada)Tetra Bio-Pharma Inc. Announces Listing of WarrantsTSXV:TBPTetra Bio Pharma Inc
13/02/202015h58PR Newswire (Canada)Tetra Bio-Pharma Announces Closing of Bought Deal FinancingTSXV:TBPTetra Bio Pharma Inc
03/02/202014h55PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - TBPTSXV:TBPTetra Bio Pharma Inc
03/02/202014h54PR Newswire (Canada)IIROC Trading Resumption - TBPTSXV:TBPTetra Bio Pharma Inc
03/02/202014h08PR Newswire (Canada)Tetra Bio-Pharma Announces CAUMZ Program Update AND Expansion of Market Potential Following Type B Meeting with USA FDATSXV:TBPTetra Bio Pharma Inc
01/02/202001h30PR Newswire (Canada)Tetra Bio-Pharma Receives Favorable Response Following Type B Meeting with USA FDA for CAUMZ™TSXV:TBPTetra Bio Pharma Inc
30/01/202020h57PR Newswire (Canada)IIROC Trading Halt - TBPTSXV:TBPTetra Bio Pharma Inc
27/01/202014h30PR Newswire (Canada)Tetra Bio-Pharma annonce l'augmentation de la taille du placement déjà annoncéTSXV:TBPTetra Bio Pharma Inc
27/01/202014h30PR Newswire (Canada)Tetra Bio-Pharma Announces Upsizing of Previously Announced OfferingTSXV:TBPTetra Bio Pharma Inc
22/01/202015h37PR Newswire (Canada)Tetra Bio-Pharma annonce un placement par voie de prise ferme de 10,0 millions de dollarsTSXV:TBPTetra Bio Pharma Inc
22/01/202015h34PR Newswire (Canada)TETRA BIO-PHARMA - PRESS RELEASE CORRECTIONTSXV:TBPTetra Bio Pharma Inc
 Showing the most relevant articles for your search:TSXV:TBP

Kürzlich von Ihnen besucht

AMEX
XLV
Health Care Select Sector
NYSE
JPM
JP Morgan Chase
NYSE
XOM
Exxon Mobil
TG
NOV
Novo Nordisk
TG
TUI1
Tui
NYSE
MCD
McDonalds
COIN
AVAXUSD
Avalanche
FX
EURGBP
Euro vs Sterling
CCOM
US100
US Tech 100
COIN
DOGEUSD
Dogecoin
COIN
BTCUSD
Bitcoin
FX
EURUSD
Euro vs US Dollar
USOTC
RHHBY
Roche (QX)
TG
BAYN
Bayer
TG
RHM
Rheinmetall
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten